阿摩線上測驗 登入

試題詳解

試卷:110年 - 110 國立臺灣大學_碩士班招生考試_臨床藥學研究所:臨床藥學及治療學#102126 | 科目:研究所、轉學考(插大)◆臨床藥學及治療學

試卷資訊

試卷名稱:110年 - 110 國立臺灣大學_碩士班招生考試_臨床藥學研究所:臨床藥學及治療學#102126

年份:110年

科目:研究所、轉學考(插大)◆臨床藥學及治療學

11. Published guidelines exist for management of care following an AM! to promote secondary prevention and to minimize the risk of developing HF. Which of the following is incorrect?
(A) Nearly 22% percentage of patients who experienced an AMI went on to develop heart failure (HF).
(B) The pattern of BNP dynam mic change ge within the first w week of the MI event is monophasic and increases linearly.
(C) Drigs that help to minimize the risk of Hr include beta-blockers (BBs), angiotensin con nverting-enzyr yme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and mineralocorticoid receptor antagonists (MRAs). The utilization of BBs, ARBS, and A CE-inhibitors post-MI is good, while the use of MRAs is marginal.
(D) Evidence from the Europ ociety of Cardiology (ESC) Heart Failure Long Term Registry showed that reaching target doses has been better achieved in ACE inhibitors and MRAs.
正確答案:登入後查看